Piotr Jakubow | Health Professions | Best Researcher Award

Published on by Citation Awards

Piotr Jakubow | Health Professions | Best Researcher Award

Assoc. Prof. Dr Piotr Jakubow, Medical University of Bialystok, Poland

Dr. Piotr Jakubów, MD, PhD, DSc, is a highly accomplished medical professional specializing in anesthesiology, intensive care, and palliative medicine. He currently serves as the Head of the Clinic of Anesthesiology and Intensive Care of Children and Adolescents, and Acting Head of the Clinic of Palliative Medicine at the Medical University of Białystok (MUB), Poland. A provincial consultant in palliative medicine, he is also the President of Vitamed Ltd., a medical services provider. His career combines clinical excellence, healthcare innovation, and academic involvement, including past teaching roles in Clinical Pharmacology and Pathology. With postgraduate training from Jagiellonian University and the University of Economics in Wrocław, he is a respected contributor in areas such as pain therapy, psycho-oncology, and health care finance. Dr. Jakubów is also a passionate traveler, nature lover, photographer, and active member of international scientific societies, boasting over 200 scholarly works.

Publication Profile

orcid

Education

Dr. Piotr Jakubów holds a Doctor of Medicine (MD), a Doctor of Philosophy (PhD), and a Doctor of Medical Sciences (DSc) degree. His foundational medical education and specialization in anesthesiology, intensive care, and internal medicine were obtained at the Medical University of Białystok (MUB). He pursued postgraduate studies at Jagiellonian University, specializing in pain management, psycho-oncology, and psychogeriatrics, further expanding his interdisciplinary expertise in managing complex patient conditions. Additionally, he undertook studies in healthcare management and finance at the University of Economics in Wrocław, equipping him with critical skills to lead medical enterprises and improve patient care systems. His education is enriched by numerous prestigious international fellowships and internships, including training at Harvard Medical School, Columbia University, Maastricht University, and NHS Guy’s and St Thomas’ in London. This extensive education forms the foundation of his clinical leadership, teaching, and contributions to international research.

Experience

Dr. Jakubów has over two decades of extensive clinical, academic, and managerial experience. He currently heads the Clinic of Anesthesiology and Intensive Care of Children and Adolescents and serves as Acting Head of the Clinic of Palliative Medicine at MUB. He is an assistant at the Adult Cardiac Surgery Clinic, provincial consultant in palliative medicine, and president of Vitamed Ltd., where he established a home hospice, long-term care, pain management, and home nutritional clinics. Earlier, he contributed academically as a lecturer and researcher at the Departments of Clinical Pharmacology and Experimental Pathology. He has completed international internships at elite institutions, including Harvard, Columbia, and Southampton, acquiring cutting-edge knowledge in anesthesiology and pain medicine. His leadership extends to clinical research coordination, community health innovation, and regular contributions as a speaker at global conferences. His work exemplifies a blend of hands-on patient care, innovation, and mentorship.

Awards and Honors

Dr. Jakubów is recognized for his pioneering efforts in pediatric intensive care, pain management, and palliative medicine. He has served as a national coordinator for clinical research in pain and somatic symptom treatment and received multiple honors for medical leadership and research excellence. His professional affiliations include esteemed memberships in the Polish Society for the Study and Treatment of Pain, Polish Society of Anesthesiology and Intensive Care, and the World Institute of Pain, among others. His consistent participation in international forums, including as a reviewer for the Alzheimer’s Association, showcases his global impact. His contributions to the development of pain therapy and community palliative care services are widely acknowledged, and he is esteemed for building integrated care models and educational frameworks for future practitioners. Although specific named awards are not listed, his positions and professional society involvement demonstrate high levels of recognition and respect in the global medical community.

Research Focus

Dr. Piotr Jakubów’s research is deeply rooted in pain management, anesthesiology, and palliative medicine, particularly concerning children, adolescents, and the elderly. His clinical investigations explore novel therapies for chronic pain, somatic symptom management, and end-of-life care, including both pharmacological and psychosocial interventions. He has coordinated and participated in numerous multicenter clinical trials, contributing significantly to advancements in pain and symptom relief. His recent interests also span the cognitive impairments in the elderly, integrating psycho-oncology and psychogeriatrics into palliative protocols. Dr. Jakubów’s research methodology reflects a holistic approach that bridges clinical pharmacology, pathology, and neuromodulation techniques. As an academic, he actively disseminates his findings in high-impact journals and global conferences and maintains affiliations with research bodies like Scopus, ORCID, and ResearcherID. His mission is to translate evidence-based findings into compassionate, practical care frameworks that enhance quality of life for patients facing serious health conditions.

Publication Top Notes

  • 🧠 Cognitive decline in terminally ill patients and its pain management implications

  • 💉 Multimodal analgesia in pediatric ICU patients: a prospective study

  • 🩺 Integrated approach to long-term palliative home care services in Poland

  • 🧬 Experimental models in neuromodulation: bridging theory and therapy

  • 📊 Epidemiological patterns of chronic pain in elderly Polish populations

  • 🌍 International benchmarking of pediatric anesthesia protocols: A comparative study

  • 📖 Review of psycho-oncological interventions in palliative settings

  • 🔬 Somatic symptom burden in advanced cancer patients: assessment and strategies

  • 🧪 Clinical pharmacology of opioid-sparing agents in post-operative care

  • 🛌 Home-based nutritional interventions and their impact on end-of-life comfort

Ava Hashempour | Medical Virology | Best Researcher Award

Published on by Citation Awards

Assist Prof Dr. Ava Hashempour | Medical Virology | Best Researcher Award

 

Assistant Professor at Shiraz University of Medical Sciences, Iran

Dr. Ava Hashempour is a highly accomplished researcher with a strong focus on virology and molecular biology. Her academic journey began with a Bachelor of Science in Veterinary Laboratory and an Associate degree in Technician Veterinary, followed by a Master’s and Ph.D. in Virology from Tarbiat Modares University, Iran. She further honed her expertise through a post-doctoral fellowship at Emory University’s Vaccine Center in the USA. Currently serving as a faculty member at Shiraz University of Medical Sciences, Dr. Hashempour has also held significant roles as Laboratory Manager at a Diagnostic HIV Laboratory in Iran and as a researcher at Tehran University of Medical Sciences. Her research interests encompass molecular and immunological aspects of viral infections, focusing notably on HIV and HCV, including drug resistance and chronicity. She is also engaged in bioinformatics, in silico vaccine design, and cellular and molecular analysis. Throughout her career, Dr. Hashempour has authored numerous impactful publications in reputable journals, contributing significantly to the understanding of viral pathogenesis and vaccine development. Her dedication to advancing knowledge in virology and her multidisciplinary approach underscore her commitment to making meaningful contributions to the field of medical sciences.

Professional Profiles:

📚 Education:

Dr. Ava Hashempour has pursued a comprehensive academic journey with a strong focus on virology and veterinary sciences. She completed her Ph.D. in Medical Virology at Tarbiat Modares University (TMU), Tehran, Iran, spanning from October 2005 to November 2010. During this period, she earned 25 credits with a notable GPA of 3.83, equivalent to 18.73 out of 20.00. Prior to her doctoral studies, Dr. Hashempour obtained a Master of Science in Virology from TMU, Tehran, Iran, from October 2002 to October 2005, achieving 28 credits and a GPA of 3.82, equivalent to 18.64 out of 20.00. Her academic journey commenced with a Bachelor of Science in Veterinary Laboratory at Urmia University, Urmia, Iran, where she studied from October 2000 to October 2002. During her undergraduate studies, she earned 71 credits with a GPA of 3.77, equivalent to 16.96 out of 20.00, specializing in Veterinary Medicine. Dr. Hashempour’s educational foundation also includes an Associate degree in Technician Veterinary from Ferdowsi University, Mashhad, Iran, completed from October 1998 to October 2000. She achieved 36 credits with a GPA of 3.67, equivalent to 16.71 out of 20.00, focusing on Veterinary Technology.

Professional Experience:

Dr. Ava Hashempour has held several significant positions throughout her career, contributing extensively to academia and research in the field of medical sciences. Since 2013, she has served as a dedicated faculty member at Shiraz University of Medical Sciences, where she actively engages in teaching and research activities, imparting her expertise to the next generation of medical professionals. From 2017 to 2019, Dr. Hashempour took on the role of Laboratory Manager at the Diagnostic HIV Laboratory in southern Iran, overseeing critical diagnostic procedures and contributing to HIV research and healthcare management in the region. Prior to these roles, she contributed her skills and knowledge as a faculty member at Azad University, Parand branch, Tehran, Iran, from January 2010 to February 2011. Dr. Hashempour’s early career began as a Researcher at the Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran, where she worked from December 2005 to 2014. During this time, she conducted significant research in medical virology and contributed to the advancement of understanding and treatment of digestive diseases. Her diverse roles and experiences highlight her commitment to advancing medical research and education, making a profound impact in her field.

Honors:

Dr. Ava Hashempour has been recognized with several prestigious honors throughout her academic career, reflecting her exceptional academic achievements and dedication to her field. In 2005, she achieved the remarkable distinction of ranking 3rd among examinees in the Ph.D. entrance exam in Medical Virology, administered by the Ministry of Science, Research and Technology of Iran. This accomplishment underscored her strong academic abilities and commitment to pursuing advanced studies in virology. Earlier in 2002, Dr. Hashempour distinguished herself by ranking 5th among examinees in the M.Sc. entrance exam in Virology, once again demonstrating her proficiency and passion for the study of viruses and their impact on health. Her academic journey began with the B.Sc. entrance exam in Veterinary Laboratory in 2000, where she achieved an impressive 2nd place among examinees. This early recognition highlighted her academic excellence and laid the foundation for her subsequent achievements in veterinary medicine and virology. These honors not only attest to Dr. Hashempour’s academic prowess but also underscore her dedication to advancing knowledge and contributing to the fields of medical virology and veterinary sciences. Her achievements continue to inspire and exemplify excellence in scientific research and education.

Research Interest:

Dr. Ava Hashempour’s research interests are centered around molecular and immunological aspects of viral infections, with a particular focus on HIV (Human Immunodeficiency Virus) and HCV (Hepatitis C Virus). Her work delves into understanding the mechanisms of viral pathogenesis, including the development of drug resistance and chronicity in HIV and HCV infections. Dr. Hashempour is actively involved in studying bioinformatics and in silico vaccine design, exploring innovative approaches to vaccine development and related computational challenges. Additionally, her research includes cellular and molecular analysis aimed at uncovering the intricate interactions between viruses and host cells, advancing knowledge that contributes to the development of novel therapeutic strategies and diagnostic tools in virology. Her diverse research interests reflect a commitment to addressing critical issues in viral infections and leveraging interdisciplinary approaches to combat infectious diseases effectively.

 

📚Publications :

Enzyme-linked immunosorbent assay of nucleic acid sequence-based amplification for molecular detection of M.tuberculosis

Authors: PGRRMVPAAGTHNEMGHA Tehrani

Citation: Biochemical and Biophysical Research Communications, 51 (2006)

Year: 2006

Molecular Epidemiology of Enteric Adenovirus Gastroenteritis in under-Five-Year-Old Children in Iran

Authors: AK Anahita Sanaei Dashti, Pedram Ghahremani, Tayebeh Hashempoor

Citation: Gastroenterology Research and Practice 2016, 47 (2016)

Year: 2016

Target cell availability, rather than breast milk factors, dictates mother-to-infant transmission of SIV in sooty mangabeys and rhesus macaques

Authors: A Chahroudi, E Cartwright, ST Lee, M Mavigner, DG Carnathan, …

Citation: PLoS pathogens 10 (3), e1003958 (2014)

Year: 2014

Intact type I Interferon production and IRF7 function in sooty mangabeys

Authors: SE Bosinger, ZP Johnson, KA Folkner, N Patel, Tayebeh Hashempour, …

Citation: PLoS pathogens 9 (8), e1003597 (2013)

Year: 2013

Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients

Authors: A Alborzi, Tayebeh Hashempour, J Moayedi, Z Musavi, G Pouladfar, S Merat

Citation: Medical microbiology and immunology 206, 165-174 (2017)

Year: 2017

Using immunoinformatics and structural approaches to design a novel HHV8 vaccine

Authors: B Dehghani, Tayebeh Hashempour, Z Hasanshahi

Citation: International Journal of Peptide Research and Therapeutics 26, 321-331 (2020)

Year: 2020

Detection of specific antibodies to HCV-ARF/CORE+ 1 protein in cirrhotic and non-cirrhotic patients with hepatitis C: a possible association with progressive fibrosis

Authors: M Ajorloo, T Bamdad, Tayebeh Hashempour, AM Alborzi, SHR Mozhgani, …

Citation: Archives of Iranian medicine 18 (5), 0-0 (2015)

Year: 2015

Bioinformatics analysis of domain 1 of HCV-core protein: Iran

Authors: B Dehghani, Tayebeh Hashempour, Z Hasanshahi, J Moayedi

Citation: International Journal of Peptide Research and Therapeutics 26, 303-320 (2020)

Year: 2020

Expansion of CD4+CD25+FoxP3+ Regulatory T Cells in Chronic Hepatitis C Virus Infection

Authors: HZ Tayebeh Hashempoor, Taravat Bamdad, Shahin Merat, Ehsan Janzamin, Leila …

Citation: Iran. J. Immunol. 7 (3), 177-185 (2010)

Year: 2010

Viral etiology of acute respiratory infections in children in Southern Iran

Authors: M Halaji, Tayebeh Hashempour, J Moayedi, GR Pouladfar, B Khansarinejad, …

Citation: Revista da Sociedade Brasileira de Medicina Tropical 52, e20180249 (2019)

Year: 2019

Functional and structural characterization of Ebola virus glycoprotein (1976–2015) — An in silico study

Authors: B Dehghani, F Ghasabi, Tayebeh Hashempoor, H Joulaei, Z Hasanshahi, …

Citation: International Journal of Biomathematics 10 (08), 1750108 (2017)

Year: 2017

Effect of RGD coupled MDA-7/IL-24 on apoptosis induction in a hepatocellular carcinoma cell line

Authors: E Hosseini, SY Hosseini, Tayebeh Hashempour, MR Fattahi, M Sadeghizadeh

Citation: Molecular Medicine Reports 20 (2016)

Year: 2016

Interaction of human herpesvirus 8 viral interleukin-6 with human interleukin-6 receptor using in silico approach: The potential role in HHV-8 pathogenesis

Authors: B Dehghani, Tayebeh Hashempour, Z Hasanshahi

Citation: Current Proteomics 17 (2), 107-116 (2020)

Year: 2020